PatientView published the results of its latest ‘Corporate Reputation of Pharma’ survey — now in its 11th year, and two years into the COVID-19 pandemic.
Between November 2021-February 2022, the survey collected the opinions of 2,150 patient groups on the performance of the pharmaceutical industry during 2021. Patient groups responding to 2021’s ‘Corporate Reputation of Pharma’ survey are uniquely positioned to comment on the pharma industry’s performance during the pandemic. Patient groups not only understand the perceptions of patients, but are also the only healthcare stakeholder to network with all other stakeholders in the healthcare system.
A summary of the survey results can be accessed here.
Source : PatientView
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.